1. Home
  2. LASE vs INMB Comparison

LASE vs INMB Comparison

Compare LASE & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laser Photonics Corporation

LASE

Laser Photonics Corporation

HOLD

Current Price

$0.98

Market Cap

55.3M

Sector

Industrials

ML Signal

HOLD

INMB

INmune Bio Inc.

HOLD

Current Price

$1.77

Market Cap

45.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LASE
INMB
Founded
2019
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.3M
45.7M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
LASE
INMB
Price
$0.98
$1.77
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$5.40
AVG Volume (30 Days)
2.8M
694.2K
Earning Date
04-20-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
11.85
EPS
N/A
N/A
Revenue
$721,185.00
$50,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
257.14
52 Week Low
$0.38
$1.09
52 Week High
$6.77
$2.96

Technical Indicators

Market Signals
Indicator
LASE
INMB
Relative Strength Index (RSI) 36.92 48.29
Support Level $0.83 $1.21
Resistance Level $1.22 $1.76
Average True Range (ATR) 0.11 0.16
MACD -0.00 -0.04
Stochastic Oscillator 28.41 14.41

Price Performance

Historical Comparison
LASE
INMB

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasive blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, machine manufacturing, nuclear maintenance and decommissioning, and surface coating. Geographically, the company generates almost all of its revenue from the domestic market.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: